Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
16.54
-0.17 (-1.02%)
At close: Jun 27, 2025, 4:00 PM
16.16
-0.38 (-2.30%)
After-hours: Jun 27, 2025, 5:40 PM EDT
Tourmaline Bio Market Cap
Tourmaline Bio has a market cap or net worth of $424.89 million as of June 27, 2025. Its market cap has increased by 22.27% in one year.
Market Cap
424.89M
Enterprise Value
175.78M
1-Year Change
22.27%
Ranking
Category
Stock Price
$16.54
Market Cap Chart
Since October 20, 2023, Tourmaline Bio's market cap has increased from $221.67M to $424.89M, an increase of 91.67%. That is a compound annual growth rate of 47.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 432.34M | -16.86% |
| Dec 31, 2024 | 520.03M | -2.33% |
| Dec 29, 2023 | 532.42M | 140.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |